TCL Archive ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention January 10, 1997
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts February 15, 1985
TCL Archive Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds July 29, 2005